A U.S. bankruptcy judge has approved Purdue Pharma and Sacklers’ $6 billion settlement agreement with the states, according to Connecticut AG
“No settlement will ever come close to remedying the magnitude of the suffering and damage caused by Purdue and the Sackler family,” Tong said in a statement. “But in reaching this $6 billion settlement, we recognized that we could not block this process forever for the victims and our sister states.”
Tong added that there will be a hearing on Thursday which will give “victims and survivors the opportunity to speak directly to the Sacklers and share in the damage and destruction they have caused.”
“We are not done fighting for justice against the addiction industry,” Tong said.
As part of the agreement, the Sackler families will authorize any institution or organization in the country to remove the Sackler name from physical facilities and academic, medical and cultural programs, scholarships and endowments as long as the Sacklers are notified first and that public statements announcing the estrangement’s name do not “disparage” the family.
In a pre-drafted statement, the Sackler families said they were “pleased to have reached a settlement with additional states that will allow very substantial additional resources to reach people and communities in need.”
“The families have consistently maintained that the settlement is by far the best way to help resolve a serious and complex public health crisis. Although the families acted lawfully in all respects, they sincerely regret that OxyContin, a drug on prescription that continues to help people with chronic pain, has unexpectedly become part of an opioid crisis that has caused heartbreak and loss to far too many families and communities,” he said. added.